Skip to main content
. Author manuscript; available in PMC: 2008 Oct 1.
Published in final edited form as: Lung Cancer. 2007 Jul 3;58(1):95–103. doi: 10.1016/j.lungcan.2007.05.017

Table 5.

Progression-free survival (PFS) and overall survival (OS)

Source (reference) Median PFS in months (95% CI) 1-year survival (%) OS in months Median follow-up (months)
1st line therapy Inoue (43) 9.7 (7.4–9.9) - not reached 7.6
Asahina (44) 8.9 (6.7–11.1) 83% not reached 12.7
Mixed 1st and subsequent lines of therapy Sutani (45) 9.4 (-) - 15.4 -
Yoshida (46) 7.7 (-) 80% not reached -
Sunaga (47) 12.9 (-) 85% not reached 12.6

PFS, progression-free survival; OS, overall survival; -, not reported in the published material